(2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine

C14H15N7O2 — CID 124744190

IUPAC(2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine
SMILESCc1nc([C@H]2CN(c3nnnn3-c3ccccc3)CCO2)no1
InChIInChI=1S/C14H15N7O2/c1-10-15-13(17-23-10)12-9-20(7-8-22-12)14-16-18-19-21(14)11-5-3-2-4-6-11/h2-6,12H,7-9H2,1H3/t12-/m1/s1
InChIKeyZVHMODQRTZNVMS-GFCCVEGCSA-N
MW313.32 g/mol
LogP0.93
Rot. Bonds3

About (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine

(2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine (PubChem CID 124744190) has the molecular formula C14H15N7O2 and a molecular weight of 313.32 g/mol. Its IUPAC name is (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine.

Molecular Properties

Compound Name(2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine
PubChem CID124744190
Molecular FormulaC14H15N7O2
Molecular Weight313.32 g/mol
Exact Mass313.13
IUPAC Name(2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine
SMILESCc1nc([C@H]2CN(c3nnnn3-c3ccccc3)CCO2)no1
InChIInChI=1S/C14H15N7O2/c1-10-15-13(17-23-10)12-9-20(7-8-22-12)14-16-18-19-21(14)11-5-3-2-4-6-11/h2-6,12H,7-9H2,1H3/t12-/m1/s1
InChIKeyZVHMODQRTZNVMS-GFCCVEGCSA-N
XLogP0.93
TPSA94.99 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500313.32
LogP ≤ 50.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Analyze (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(1-phenyltetrazol-5-yl)-2-thiophen-2-ylmorpholine
CID 133363497
2-(2-methylphenyl)-4-[1-(4-methylphenyl)tetrazol-5-yl]morpholine
CID 133354117
2-(bromomethyl)-4-(1-phenyltetrazol-5-yl)morpholine
CID 81211012
2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(2-phenylpyrimidin-4-yl)morpholine
CID 75466960
4-(1-phenyltetrazol-5-yl)-2-[4-(trifluoromethyl)phenyl]morpholine
CID 133449904
4-[1-(4-methylphenyl)tetrazol-5-yl]-2-phenyl-1,4-oxazepane
CID 138998130
4-(5-bromopyrimidin-2-yl)-2-(5-methyl-1,2,4-oxadiazol-3-yl)morpholine
CID 127299170
[(2S)-2-(5-methyl-1,2,4-oxadiazol-3-yl)morpholin-4-yl]-[1-phenyl-5-(trifluoromethyl)pyrazol-4-yl]methanone
CID 97344994
N-methyl-1-(1-phenyltetrazol-5-yl)piperidin-3-amine
CID 55084372
(3R)-1-(1-phenyltetrazol-5-yl)piperidin-3-amine
CID 102986512
1-phenyl-5-[(3S)-3-pyrrolidin-1-ylpyrrolidin-1-yl]tetrazole
CID 97262694
4-[1-(4-methylphenyl)tetrazol-5-yl]-2-[(4-methylpyrazol-1-yl)methyl]morpholine
CID 133281997

Frequently Asked Questions

What is the IUPAC name of (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine?
The IUPAC name of (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine (CID 124744190) is (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine.
What is the SMILES notation for (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine?
The canonical SMILES for (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine is Cc1nc([C@H]2CN(c3nnnn3-c3ccccc3)CCO2)no1.
What is the InChIKey of (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine?
The InChIKey is ZVHMODQRTZNVMS-GFCCVEGCSA-N. The full InChI is InChI=1S/C14H15N7O2/c1-10-15-13(17-23-10)12-9-20(7-8-22-12)14-16-18-19-21(14)11-5-3-2-4-6-11/h2-6,12H,7-9H2,1H3/t12-/m1/s1.
What are the key properties of (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine?
(2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine has a molecular weight of 313.32 g/mol, XLogP of 0.93, 3 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(1-phenyltetrazol-5-yl)morpholine is sourced from PubChem (CID 124744190), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).